000			02048 a2200613 4500
005			20250518043111.0
264		0	_c20200601
008			202006s 0 0 eng d
022			_a1440-1746
024	7		_a10.1111/jgh.14751 _2doi
040			_aNLM _beng _cNLM
100	1		_aWang, Yunwei
245	0	0	_aOutcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission. _h[electronic resource]
260			_bJournal of gastroenterology and hepatology _cDec 2019
300			_a2090-2095 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal, Humanized _xadverse effects
650	0	4	_aColitis, Ulcerative _xdrug therapy
650	0	4	_aColonoscopy
650	0	4	_aCrohn Disease _xdrug therapy
650	0	4	_aDrug Substitution _xmethods
650	0	4	_aFemale
650	0	4	_aGastrointestinal Agents _xadverse effects
650	0	4	_aHumans
650	0	4	_aInflammatory Bowel Diseases _xdrug therapy
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aRemission Induction
650	0	4	_aRetrospective Studies
650	0	4	_aSeverity of Illness Index
650	0	4	_aTreatment Outcome
650	0	4	_aTumor Necrosis Factor Inhibitors _xtherapeutic use
650	0	4	_aYoung Adult
700	1		_aWang, Jennifer
700	1		_aPekow, Joel
700	1		_aDalal, Sushila
700	1		_aCohen, Russell D
700	1		_aOllech, Jacob
700	1		_aIsrael, Amanda
700	1		_aShogan, Benjamin D
700	1		_aMicic, Dejan
700	1		_aCannon, Lisa
700	1		_aUmanskiy, Konstantin
700	1		_aHurst, Roger
700	1		_aHyman, Neil
700	1		_aRubin, David T
700	1		_aSakuraba, Atsushi
773	0		_tJournal of gastroenterology and hepatology _gvol. 34 _gno. 12 _gp. 2090-2095
856	4	0	_uhttps://doi.org/10.1111/jgh.14751 _zAvailable from publisher's website
999			_c29769855 _d29769855